These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32433960)

  • 1. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Mature Primary Innate Immune Cells.
    Riggan L; Hildreth AD; Rolot M; Wong YY; Satyadi W; Sun R; Huerta C; O'Sullivan TE
    Cell Rep; 2020 May; 31(7):107651. PubMed ID: 32433960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
    Hildreth AD; Riggan L; O'Sullivan TE
    STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient and stable CRISPR/Cas9-mediated genome-editing of human type 2 innate lymphoid cells.
    Audouze-Chaud J; Mathews JA; Crome SQ
    Front Immunol; 2023; 14():1275413. PubMed ID: 37868976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for genomic editing in human resting primary NK cells and NK-92 cells via CRISPR-Cas9 ribonucleoproteins.
    Verhezen T; Lau HW; Van Audenaerde J; Wouters A; Smits E; De Waele J
    STAR Protoc; 2024 Sep; 5(3):103123. PubMed ID: 38935511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipofection-Based Delivery of CRISPR/Cas9 Ribonucleoprotein for Gene Editing in Male Germline Stem Cells.
    Obermeier M; Rogiers V; Vanhaecke T; Baert Y
    Methods Mol Biol; 2024; 2770():123-134. PubMed ID: 38351451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
    Wilbie D; Walther J; Mastrobattista E
    Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonucleoproteins Mediated Efficient In Vivo Gene Editing in Skin Stem Cells.
    Wu W; Chen T
    Methods Mol Biol; 2019; 1879():75-86. PubMed ID: 30426459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
    Chen S; Lee B; Lee AY; Modzelewski AJ; He L
    J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
    Bloomer H; Khirallah J; Li Y; Xu Q
    Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Mediated Construction of Gene-Knockout Mice for Investigating Antiviral Innate Immunity.
    Shen Y; Zhao X; Zheng C; Chen Q
    Methods Mol Biol; 2025; 2854():61-74. PubMed ID: 39192119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex Vivo Expansion and CRISPR-Cas9 Genome Editing of Primary Human Natural Killer Cells.
    Huang RS; Lai MC; Lin S
    Curr Protoc; 2021 Sep; 1(9):e246. PubMed ID: 34529358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells.
    Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN
    Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.
    Lattanzi A; Meneghini V; Pavani G; Amor F; Ramadier S; Felix T; Antoniani C; Masson C; Alibeu O; Lee C; Porteus MH; Bao G; Amendola M; Mavilio F; Miccio A
    Mol Ther; 2019 Jan; 27(1):137-150. PubMed ID: 30424953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editing the immune system in vivo in mice using CRISPR/Cas9 ribonucleoprotein (RNP)-mediated gene editing of transplanted hematopoietic stem cells.
    Wang R; Graham S; Gao L; Tam J; Levesque MC
    Methods; 2021 Oct; 194():30-36. PubMed ID: 33422676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
    Wu W; Lu Z; Li F; Wang W; Qian N; Duan J; Zhang Y; Wang F; Chen T
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1660-1665. PubMed ID: 28137859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins.
    Naeimi Kararoudi M; Dolatshad H; Trikha P; Hussain SA; Elmas E; Foltz JA; Moseman JE; Thakkar A; Nakkula RJ; Lamb M; Chakravarti N; McLaughlin KJ; Lee DA
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 29985369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-Viral Extracellular Nanoparticles.
    Mazurov D; Ramadan L; Kruglova N
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient Multi-Allelic Genome Editing of Primary Cell Cultures via CRISPR-Cas9 Ribonucleoprotein Nucleofection.
    Hoellerbauer P; Kufeld M; Paddison PJ
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e126. PubMed ID: 32833346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation.
    Ma L; Jang L; Chen J; Song J; Yang D; Zhang J; Chen YE; Xu J
    J Vis Exp; 2019 Jun; (148):. PubMed ID: 31282887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.